Management of type 2 diabetes: A handbook for general practice

Preventing progression to type 2 diabetes

Preventing progression to type 2 diabetes


Recommendation 

Grade 

References 

Recommended as of:

People with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) should be referred to lifestyle intervention programs to: 

  • achieve and maintain a 7% reduction in weight 

  • achieve a moderate-intensity physical activity to at least 150 minutes per week 

14/11/2024

People with glycated haemoglobin (HbA1c) 6.0–6.4% may also benefit from a structured weight loss and exercise program to reduce their risk of developing type 2 diabetes 

D, Consensus 

14/11/2024

Defining risk 

Risk factors for type 2 diabetes include:

  • demographic and social factors – age, family history, ethnicity 
  • lifestyle factors – obesity, physical inactivity, smoking 
  • clinical history – high blood pressure, high triglycerides and low high-density lipoprotein cholesterol (HDL-C), gestational diabetes, heart disease, stroke, depression, polycystic ovary syndrome, acanthosis nigricans and metabolic-associated fatty liver disease (MALFD) 
  • medications – including corticosteroids and antipsychotic medications. 

Clinicians should be alert to the possibility of type 2 diabetes in people with these risk factors, many of which are also risk factors for cardiovascular disease. 

The ‘metabolic syndrome’ (defined by the presence of at-risk measures for waist circumference, triglycerides, HDL-C, blood pressure and fasting glucose4) confers a three- to fivefold increased risk of type 2 diabetes, as well as an increased risk for cardiovascular disease.5 

People with MALFD are at twice the risk of developing type 2 diabetes as the general population.6 

Particular population groups are also at greater risk of developing type 2 diabetes, such as those with a high-risk ethnicity/background (Aboriginal and Torres Strait Islander, South Asian, South-East Asian, North African, Latin American, Middle Eastern, Māori or Pacific Islander people, including individuals of mixed ethnicity).7 (Refer to ‘Who is at risk of type 2 diabetes?’ in the section ‘Defining and diagnosing type 2 diabetes’.) 

Aboriginal and Torres Strait Islander peoples have more than three times the prevalence of type 2 diabetes than non-Indigenous Australians, with onset at an earlier age.8 Waist circumference has been found to be a strong predictor of the risk of developing type 2 diabetes, especially in Aboriginal women.9 For advice on the prevention of type 2 diabetes refer to ‘Chapter 17: Type 2 diabetes’ in the National Aboriginal Community Controlled Health Organisation (NACCHO)–Royal Australian College of General Practitioners (RACGP) National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people.10 

Other groups particularly at high risk of developing type 2 diabetes are people with IFG, IGT or gestational diabetes.11,12 (For definitions of these states, refer to ‘Defining and diagnosing type 2 diabetes’.) 

Progression to type 2 diabetes in people at high risk 

Annually, approximately 5–10% of people at high risk develop diabetes, although this varies according to age, sex, family history and ethnic background.13 Three-quarters of people with IFG or IGT will develop type 2 diabetes over their lifetime.14 People with IFG or IGT whose glucose metabolism returns to normal, either as a result of interventions or spontaneously, have roughly half the risk of developing type 2 diabetes compared with those with persistently abnormal glucose metabolism.15 

Women with a history of gestational diabetes have an approximate 7- to 10-fold16 elevated risk of future development of type 2 diabetes depending on diagnostic criteria applied to this population.17–19 

Evidence for lifestyle interventions to prevent type 2 diabetes 

In randomised controlled trials, intensive lifestyle interventions have been shown to reduce the rates of progression to type 2 diabetes by 27–45% over periods ranging from 10 to 23 years.1 Recent analyses suggest that longer-term (more than three years) with sustained (mixed lifestyle and medication) interventions may reduce the risks of cardiovascular disease, retinopathy and mortality in identified high-risk people across different population groups.20 (Refer to ‘Who is at risk of type 2 diabetes?’ in ‘Defining and diagnosing type 2 diabetes’.) 

People at high risk of type 2 diabetes should consider lifestyle interventions to help them increase physical activity to at least 150 minutes per week, and to achieve and maintain a 7% reduction in weight if they are overweight or obese. This may involve individual or group education and coaching. Cardiovascular fitness significantly decreases the risk of progression to type 2 diabetes in people with IFG and/or IGT, whether or not they are overweight.21 

In women with a history of gestational diabetes, beginning lifestyle interventions soon after pregnancy has been shown to reduce the incidence of type 2 diabetes by 25%.22 

Other interventions 

There is evidence that, in high-risk people, metformin reduces the relative risk of developing type 2 diabetes by approximately 25%.23,24 However, metformin is not licensed by the Therapeutic Goods Administration for this use in Australia. 

There have been no randomised controlled trials of the effect of bariatric surgery on preventing progression to type 2 diabetes. Longitudinal studies have observed longer-term reduction in progression from IGT to diabetes (ie return to nonormoglycaemia) at rates of 58% at four years after surgery, with only 5% progressing to diabetes. However, results are more promising for people diagnosed with diabetes and the incidence of diabetes remission.25 (Refer to ‘Remission of type 2 diabetes’.) 

Identifying people at high risk of type 2 diabetes 

Identifying risk factors for type 2 diabetes in people is a routine part of general practice. The RACGP’s Guidelines for preventive activities in general practice (10th edition) recommend assessing body mass index, waist circumference, diet and physical activity in adults every two years. Screening for diabetes risk with the Australian type 2 diabetes risk assessment tool (AUSDRISK) is recommended in all adults aged ≥40 years every three years.

For information about assessing diabetes risk and screening recommendations for diabetes, IFG and IGT, refer to ‘Defining and diagnosing type 2 diabetes’. 

Interventions to manage diabetes risk 

People at high risk of type 2 diabetes are also at increased risk of cardiovascular disease. Thus, their cardiovascular risk should be assessed, and lifestyle change and medications considered where appropriate.26 (Refer to ‘Type 2 diabetes and cardiovascular risk’.) 

Particular lifestyle interventions have been shown to reduce the risk of type 2 diabetes in people with IGT, but not in those with IFG alone. These interventions are of moderate intensity (eg at least 16 one- to two-hour sessions focusing on diet and physical activity delivered over six months by a range of health professionals). People should consider at least 150 minutes per week of physical activity27 and a low-glycaemic index diet rich in fruit, vegetables and fibre, and low in meat and fat. 

Maintaining lifestyle change, especially weight loss, in high-risk people can be difficult. Technology-assisted modalities, including ‘apps’ that support change in diet and physical activity, activity trackers and websites providing information and referral options, are promising tools to help people maintain physical activity and weight loss.28 

Intensive lifestyle intervention may be beyond the scope of the brief interventions routinely delivered in general practice or practice nurse consultations, or even by those delivered through allied health visits as part of a care plan. People may therefore benefit from referral to a diabetes prevention program. A list of state-based diabetes prevention programs can be found on the Diabetes Australia website. 

Telephone coaching programs run by state and territory governments and health insurance funds have also shown promising results.29 

Refer to the RACGP’s Smoking, nutrition, alcohol, physical activity (SNAP) guide designed to assist GPs and practice staff (the general practice team) to work with patients on the lifestyle risk factors of SNAP. 

The Australian National Diabetes Strategy 2021–2023 includes information on reducing modifiable risk factors and areas for action to prevent people developing type 2 diabetes (pp 14–15). 

  1. American Diabetes Association Professional Practice Committee. 3. Prevention or delay of diabetes and associated comorbidities: Standards of care in diabetes – 2024. Diabetes Care 2024;47(Suppl 1):S43–51. doi: 10.2337/dc24-S003.
  2. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42(Suppl 1):S1–326.
  3. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study. Arch Intern Med 2007;167(10):1068–74. doi: 10.1001/archinte.167.10.1068.
  4. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640–45. doi: 10.1161/CIRCULATIONAHA.109.192644.
  5. Shin JA, Lee JH, Lim SY, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig 2013;4(4):334–43. doi: 10.1111/jdi.12075.
  6. Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol 2016;31(5):936–44. doi: 10.1111/jgh.13264.
  7. The Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice.10th edn. RACGP, 2024 [Accessed 10 September 2024].
  8. Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE. Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review. Diabetes Res Clin Pract 2011;93(2):139–49. doi: 10.1016/j.diabres.2011.06.012.
  9. Adegbija O, Hoy W, Wang Z. Predicting absolute risk of type 2 diabetes using age and waist circumference values in an aboriginal Australian community. PLoS One 2015;10(4):e0123788. doi: 10.1371/journal.pone.0123788.
  10. National Aboriginal Community Controlled Health Organisation and The Royal Australian College of General Practitioners (RACGP). National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people. 4th edn. RACGP, 2024
  11. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 2007;30(3):753–59. doi: 10.2337/dc07-9920.
  12. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009;373(9677):1773–79. doi: 10.1016/S0140-6736(09)60731-5.
  13. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007;78(3):305–12. doi: 10.1016/j.diabres.2007.05.004.
  14. Ligthart S, van Herpt TT, Leening MJ, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: A prospective cohort study. Lancet Diabetes Endocrinol 2016;4(1):44–51. doi: 10.1016/S2213-8587(15)00362-9.
  15. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379(9833):2243–51. doi: 10.1016/S0140-6736(12)60525-X.
  16. Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis. BMJ 2020;369:m1361. doi: 10.1136/bmj.m1361.
  17. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: A systematic review and meta-analysis. Diabetologia 2019;62(6):905–14. doi: 10.1007/s00125-019-4840-2.
  18. Li J, Song C, Li C, Liu P, Sun Z, Yang X. Increased risk of cardiovascular disease in women with prior gestational diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2018;140:324–38. doi: 10.1016/j.diabres.2018.03.054.
  19. Song G, Wang C, Yang HX. Diabetes management beyond pregnancy. Chin Med J (Engl) 2017;130(9):1009–11. doi: 10.4103/0366-6999.204938.
  20. An X, Zhang Y, Sun W, et al. Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: A systematic review and meta-analysis based on high-quality clinical studies. Front Endocrinol (Lausanne) 2024;15:1294819. doi: 10.3389/fendo.2024.1294819.
  21. Lavie CJ, Johannsen N, Swift D, et al. Exercise is medicine – the importance of physical activity, exercise training, cardiorespiratory fitness and obesity in the prevention and treatment of type 2 diabetes. Eur Endocrinol 2014;10(1):18–22. doi: 10.17925/EE.2014.10.01.18.
  22. Goveia P, Cañon-Montañez W, Santos DP, et al. Lifestyle intervention for the prevention of diabetes in women with previous gestational diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2018;9:583. doi: 10.3389/fendo.2018.00583.
  23. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: Systematic review and meta-analysis of screening tests and interventions. BMJ 2017;356:i6538. doi: 10.1136/bmj.i6538.
  24. Aroda VR, Knowler WC, Crandall JP, et al. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia 2017;60(9):1601–11. doi: 10.1007/s00125-017-4361-9.
  25. Borges-Canha M, Neves JS, Silva MM, et al. Prediabetes remission after bariatric surgery: A 4-years follow-up study. BMC Endocr Disord 2024;24(1):7. doi: 10.1186/s12902-024-01537-0.
  26. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: Impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011;108(3 Suppl):3B–24B. doi: 10.1016/j.amjcard.2011.03.013.
  27. Smith AD, Crippa A, Woodcock J, Brage S. Physical activity and incident type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of prospective cohort studies. Diabetologia 2016;59(12):2527–45. doi: 10.1007/s00125-016-4079-0.
  28. Bian RR, Piatt GA, Sen A, et al. The effect of technology-mediated diabetes prevention interventions on weight: A meta-analysis. J Med Internet Res 2017;19(3):e76. doi: 10.2196/jmir.4709.
  29. Cranney L, O’Hara B, Gale J, Rissel C, Bauman A, Phongsavan P. Telephone based coaching for adults at risk of diabetes: Impact of Australia’s Get Healthy Service. Transl Behav Med 2019;9(6):1178–85. doi: 10.1093/tbm/ibz007.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log


 

Advertising